ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "High-risk"

  • 2019 American Transplant Congress

    Microsteatosis in Livers from Donation after Circulatory Death (DCD) Donors is Associated with Inferior Graft and Patient Survival Following Liver Transplantation (LTX)

    N. Bath, G. Leverson, D. Foley

    University of Wisconsin, Madison, WI

    *Purpose: The current theory is that severe macrosteatosis (MaS) (>50%) in livers recovered from donation after brain death (DBD) donors leads to increased rates of…
  • 2019 American Transplant Congress

    Consideration for Offering Hepatitis C Antibody Positive Donor Grafts to All Patients Listed for Transplant

    L. Smith

    Vanderbilt Transplant Center, Nashville, TN

    *Purpose: Background: The field of organ transplantation continuously struggles with inadequate numbers of donor organs. Therefore, efforts remain focused on increasing organ utilization and expanding…
  • 2019 American Transplant Congress

    Risk Factors for Graft Loss Vary with Recipient MELD Score in Liver Transplantation

    J. A. Steggerda1, M. B. Bloom1, T. Todo2, T. V. Brennan2, N. N. Nissen2, A. S. Klein2, I. K. Kim2

    1Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, 2Transplant Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA

    *Purpose: Risk factors for allograft loss in liver transplantation have previously been described. Less is known how these vary and interact amongst recipients with different…
  • 2019 American Transplant Congress

    Heterozygous Gene Mutations In The Complement Factor I (cfi) Was Susceptibility Gene For The C3 Glomerulonephritis In Native Kidney And Renal Allograft

    J. Wen, H. Song, X. Ni, M. Zhang, F. Xu, X. Zhu

    Jinling Hospital, Nanjing University School of Medicine, National Clinical Research Center of Kidney Diseases, Nanjing, Jiangsu, China

    *Purpose: We previously reported heterozygous c.848A > G and c.1339C > T gene mutations in the complement factor I (CFI) gene (NM_000204.3) in a kidney transplant recipient with C3…
  • 2019 American Transplant Congress

    Early Allograft Dysfunction in High Acuity Liver Transplant Recipients

    T. Ito, M. Lu, A. Murray, D. S. Graham, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

    Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA

    *Purpose: Organ recipient matching in Liver Transplantation (LT) has become ever-more challenging with the ongoing organ scarcity and increasing patient acuity. While the notion that…
  • 2019 American Transplant Congress

    Clinical, Aging, Morphometric Measures & Adverse Outcomes in Kidney Transplant Recipients

    A. Muzaale1, N. Chu1, H. Ying1, B. Ross2, D. Segev1, M. McAdams-Demarco1

    1JHU, Baltimore, MD, 2UM, Ann Habor, MI

    *Purpose: Sarcopenia is a hallmark of frailty, a geriatric phenotype which is common among kidney transplant (KT) candidates and recipients. Sarcopenic-obesity is a high-risk state…
  • 2019 American Transplant Congress

    Factors Associated with the Acceptance of Livers for Liver Transplantation: Validation of the Discard Risk Index in the Eurotransplant Region

    J. D. Boer1, H. Putter2, J. J. Blok3, N. Cambridge1, S. Van den Berg1, U. Samuel1, G. Berlakovich4, M. Guba5, A. E. Braat3

    1Eurotransplant International Foundation, Leiden, Netherlands, 2Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands, 3Transplant Center, Leiden University Medical Center, Leiden, Netherlands, 4Medical University of Vienna, Vienna, Austria, 5Hospital of the University of Munich, Munich, Germany

    *Purpose: In times of organ shortage it has to be better understood why available livers are not transplanted. This study aims to analyze factors associated…
  • 2019 American Transplant Congress

    Risk Stratification of Patients Undergoing Simultaneous Liver Transplantation and Cardiac Surgery

    T. Diago Uso, G. D'Amico, S. Armanyous, L. Lomaglio, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, N. K. Menon, M. Fares, M. Tong, K. Hashimoto, C. Miller, C. Quintini

    Cleveland Clinic, Cleveland, OH

    *Purpose: Evaluate risk factors and outcomes of combined liver transplantation (OLT) and cardiac surgery, including coronary artery grafting and valve replacement.*Methods: Between 1/2005 and 8/2018,…
  • 2019 American Transplant Congress

    Specific Reasons for Public Health Service (PHS) Increased Risk (IR) Designation Had Little Influence on Doctors’ Kidney Offer Acceptance Decisions in Controlled “Lab” Experiment

    D. Stewart1, J. Rosendale1, H. McGehee1, J. Schold2, J. Lindemans3, J. Kessler4, C. Sullivan4, K. Mekeel5, R. Stratta6, R. Formica7, D. Klassen1

    1UNOS, Richmond, VA, 2CCF, Cleveland, OH, 3Duke, Durham, NC, 4Wharton, Philadelphia, PA, 5UCSD, San Diego, CA, 6Wake Forest, Winston-Salem, NC, 7Yale, New Haven, CT

    *Purpose: Over 25% of donors are labeled as PHS “increased risk,” a designation associated with reduced organ utilization despite favorable risk/benefit calculations for most patients.…
  • 2019 American Transplant Congress

    Extreme Hyponatremia as a Risk Factor for Early Mortality after Liver Transplantation in the Model for End-Stage Liver Disease-Sodium Period

    H. Mouzaihem, M. Safwan, L. C. Chau, D. Moonka, M. Abouljoud, S. Nagai

    Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI

    *Purpose: While we reported that implementation of MELD-Na based liver allocation improved waitlist outcomes in patients with hyponatremia, its impact on post-transplant outcomes in this…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 15
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences